ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,816 | -31.5% | 33,877 | -27.3% | 0.00% | – |
Q2 2023 | $74,140 | +11.6% | 46,629 | -49.7% | 0.00% | – |
Q1 2023 | $66,462 | +65.8% | 92,643 | +34.0% | 0.00% | – |
Q4 2022 | $40,078 | +208.3% | 69,160 | +400.3% | 0.00% | – |
Q3 2022 | $13,000 | -94.4% | 13,823 | -89.5% | 0.00% | – |
Q4 2021 | $231,000 | -47.4% | 131,155 | -35.1% | 0.00% | – |
Q3 2021 | $439,000 | -79.2% | 202,240 | -66.5% | 0.00% | -100.0% |
Q2 2021 | $2,115,000 | +409.6% | 604,300 | +1336.7% | 0.00% | – |
Q1 2021 | $415,000 | -56.4% | 42,062 | -52.1% | 0.00% | – |
Q4 2020 | $952,000 | -11.8% | 87,777 | -16.2% | 0.00% | – |
Q3 2020 | $1,079,000 | -70.5% | 104,807 | -40.1% | 0.00% | -100.0% |
Q2 2020 | $3,652,000 | +2256.1% | 174,871 | +1004.2% | 0.00% | – |
Q1 2020 | $155,000 | -37.2% | 15,837 | -26.1% | 0.00% | – |
Q4 2019 | $247,000 | +11.3% | 21,441 | -47.4% | 0.00% | – |
Q3 2019 | $222,000 | +276.3% | 40,731 | +303.0% | 0.00% | – |
Q1 2018 | $59,000 | -45.4% | 10,108 | -65.9% | 0.00% | – |
Q3 2017 | $108,000 | – | 29,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |